mymedpharma limited

1.5

mymedpharma limited Company Information

Share MYMEDPHARMA LIMITED
Dissolved 

Company Number

05504955

Registered Address

mymed house, 95 -97 johnston street, blackburn, lancashire, BB2 1HY

Industry

Other human health activities

 

Telephone

-

Next Accounts Due

April 2024

Group Structure

View All

Directors

Mujahid Ali18 Years

Tabassam Zabier14 Years

Shareholders

mymedpharma holdings ltd 100%

mymedpharma limited Estimated Valuation

£0 - £15.6k

The estimated valuation range for mymedpharma limited, derived from financial data as of March 2022 and the most recent industry multiples, is between £0 to £15.6k

mymedpharma limited Estimated Valuation

£0 - £15.6k

The estimated valuation range for mymedpharma limited, derived from financial data as of March 2022 and the most recent industry multiples, is between £0 to £15.6k

mymedpharma limited Estimated Valuation

£0 - £15.6k

The estimated valuation range for mymedpharma limited, derived from financial data as of March 2022 and the most recent industry multiples, is between £0 to £15.6k

Get a detailed valuation report, edit figures and unlock valuation multiples.

Mymedpharma Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Mymedpharma Limited Overview

Mymedpharma Limited is a dissolved company that was located in blackburn, BB2 1HY with a Companies House number of 05504955. It operated in the other human health activities sector, SIC Code 86900. Founded in July 2005, it's largest shareholder was mymedpharma holdings ltd with a 100% stake. The last turnover for Mymedpharma Limited was estimated at £42.8k.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Mymedpharma Limited Health Check

Pomanda's financial health check has awarded Mymedpharma Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating1.5out of 5
positive_score

1 Strong

positive_score

2 Regular

positive_score

4 Weak

size

Size

annual sales of £42.8k, make it smaller than the average company (£738.2k)

£42.8k - Mymedpharma Limited

£738.2k - Industry AVG

growth

Growth

There is insufficient data available for this Key Performance Indicator!

- - Mymedpharma Limited

- - Industry AVG

production

Production

with a gross margin of 20.4%, this company has a higher cost of product (35.6%)

20.4% - Mymedpharma Limited

35.6% - Industry AVG

profitability

Profitability

an operating margin of -82.3% make it less profitable than the average company (8.5%)

-82.3% - Mymedpharma Limited

8.5% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (19)

1 - Mymedpharma Limited

19 - Industry AVG

paystructure

Pay Structure

on an average salary of £23.4k, the company has an equivalent pay structure (£23.4k)

£23.4k - Mymedpharma Limited

£23.4k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £42.8k, this is equally as efficient (£42.1k)

£42.8k - Mymedpharma Limited

£42.1k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Mymedpharma Limited

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 163 days, this is slower than average (16 days)

163 days - Mymedpharma Limited

16 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Mymedpharma Limited

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Mymedpharma Limited

- - Industry AVG

debtlevel

Debt Level

There is insufficient data available for this Key Performance Indicator!

- - Mymedpharma Limited

- - Industry AVG

mymedpharma limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for mymedpharma limited. Get real-time insights into mymedpharma limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Mymedpharma Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for mymedpharma limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

mymedpharma limited Ownership

MYMEDPHARMA LIMITED group structure

Mymedpharma Limited has no subsidiary companies.

Ultimate parent company

1 parent

MYMEDPHARMA LIMITED

05504955

MYMEDPHARMA LIMITED Shareholders

mymedpharma holdings ltd 100%

mymedpharma limited directors

Mymedpharma Limited currently has 2 directors. The longest serving directors include Mr Mujahid Ali (Jul 2005) and Mr Tabassam Zabier (Sep 2009).

officercountryagestartendrole
Mr Mujahid AliEngland44 years Jul 2005- Director
Mr Tabassam ZabierUnited Kingdom45 years Sep 2009- Director

MYMEDPHARMA LIMITED financials

EXPORTms excel logo

Mymedpharma Limited's latest turnover from March 2022 is estimated at £42.8 thousand and the company has net assets of -£15.2 thousand. According to their latest financial statements, Mymedpharma Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2022Mar 2021Mar 2020Sep 2018Sep 2017Sep 2016Sep 2015Sep 2014Sep 2013Sep 2012Sep 2011Sep 2010Sep 2009
Turnover42,77261,447264,090819,520763,4551,423,7991,535,9505,483,7924,477,7553,041,0053,466,5322,003,2710
Other Income Or Grants0000000000000
Cost Of Sales34,05449,804209,187647,976580,0731,083,0981,193,4724,183,8703,408,7552,213,3302,480,6381,430,0290
Gross Profit8,71811,64354,903171,544183,382340,701342,4791,299,9221,069,000827,674985,894573,2410
Admin Expenses43,91220,67920,404128,055183,334378,395400,5651,337,6381,103,118846,9381,001,937432,928-84,093
Operating Profit-35,194-9,03634,49943,48948-37,694-58,086-37,716-34,118-19,264-16,043140,31384,093
Interest Payable0000000000000
Interest Receivable035352,2261501251,0741,506946789728658316
Pre-Tax Profit-35,194-9,00134,53545,715198-37,569-57,012-36,210-33,172-18,475-15,315140,97184,410
Tax00-6,562-8,686-38000000-39,472-23,635
Profit After Tax-35,194-9,00127,97337,029160-37,569-57,012-36,210-33,172-18,475-15,315101,49960,775
Dividends Paid0000000000000
Retained Profit-35,194-9,00127,97337,029160-37,569-57,012-36,210-33,172-18,475-15,315101,49960,775
Employee Costs23,37745,639111,448148,27283,348388,157446,9191,696,9701,454,967927,2501,085,563612,4300
Number Of Employees12574192179684452300
EBITDA*-28,559-19353,74160,60348-10,810-23,584-14,049-13,631-2388,273164,34384,283

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2022Mar 2021Mar 2020Sep 2018Sep 2017Sep 2016Sep 2015Sep 2014Sep 2013Sep 2012Sep 2011Sep 2010Sep 2009
Tangible Assets034,82543,66861,37578,48999,503126,38780,42769,47965,63283,46887,296760
Intangible Assets0000000000000
Investments & Other0000000000000
Debtors (Due After 1 year)0000000000000
Total Fixed Assets034,82543,66861,37578,48999,503126,38780,42769,47965,63283,46887,296760
Stock & work in progress00057,29369,43062,10070,26064,78559,25032,0919,62800
Trade Debtors0038,819150,301233,784167,383185,369686,606585,856412,041518,410309,227112,434
Group Debtors0000000000000
Misc Debtors0044,429355,060000000000
Cash011970,464529,85663,79555,94644,402385,205217,219161,228154,424136,712126,547
misc current assets0000000000000
total current assets0119153,7121,092,510367,009285,429300,0311,136,596862,325605,360682,462445,939238,981
total assets034,944197,3801,153,885445,498384,932426,4181,217,023931,804670,992765,930533,235239,741
Bank overdraft0000000000000
Bank loan0000000000000
Trade Creditors 15,22214,97292,677372,269192,872419,411410,4671,144,060825,409531,211605,173356,117177,822
Group/Directors Accounts0000000000000
other short term finances0000000000000
hp & lease commitments0000000000000
other current liabilities0075,730778,906286,94500000000
total current liabilities15,22214,972168,4071,151,175479,817419,411410,4671,144,060825,409531,211605,173356,117177,822
loans0000000000000
hp & lease commitments0000000000000
Accruals and Deferred Income0000000000000
other liabilities0000000000000
provisions00000012,86112,86110,08310,29712,79813,844144
total long term liabilities00000012,86112,86110,08310,29712,79813,844144
total liabilities15,22214,972168,4071,151,175479,817419,411423,3281,156,921835,492541,508617,971369,961177,966
net assets-15,22219,97228,9732,710-34,319-34,4793,09060,10296,312129,484147,959163,27461,775
total shareholders funds-15,22219,97228,9732,710-34,319-34,4793,09060,10296,312129,484147,959163,27461,775
Mar 2022Mar 2021Mar 2020Sep 2018Sep 2017Sep 2016Sep 2015Sep 2014Sep 2013Sep 2012Sep 2011Sep 2010Sep 2009
Operating Activities
Operating Profit-35,194-9,03634,49943,48948-37,694-58,086-37,716-34,118-19,264-16,043140,31384,093
Depreciation6,6358,84319,24217,114026,88434,50223,66720,48719,02624,31624,030190
Amortisation0000000000000
Tax00-6,562-8,686-38000000-39,472-23,635
Stock000-12,1377,330-8,1605,4755,53527,15922,4639,62800
Debtors0-83,24883,248271,57766,401-17,986-501,237100,750173,815-106,369209,183196,793112,434
Creditors250-77,70592,677179,397-226,5398,944-733,593318,651294,198-73,962249,056178,295177,822
Accruals and Deferred Income0-75,73075,730491,961286,94500000000
Deferred Taxes & Provisions00000-12,86102,778-214-2,501-1,04613,700144
Cash flow from operations-28,309-70,380132,338463,835-13,31511,419-261,415201,09579,3797,20537,472120,073126,180
Investing Activities
capital expenditure28,1900-62,910021,0140-80,462-34,615-24,334-1,190-20,488-110,566-950
Change in Investments0000000000000
cash flow from investments28,1900-62,910021,0140-80,462-34,615-24,334-1,190-20,488-110,566-950
Financing Activities
Bank loans0000000000000
Group/Directors Accounts0000000000000
Other Short Term Loans 0000000000000
Long term loans0000000000000
Hire Purchase and Lease Commitments0000000000000
other long term liabilities0000000000000
share issue001,0000000000001,000
interest035352,2261501251,0741,506946789728658316
cash flow from financing0351,0352,2261501251,0741,5069467897286581,316
cash and cash equivalents
cash-119-70,34570,464466,0617,84911,544-340,803167,98655,9916,80417,71210,165126,547
overdraft0000000000000
change in cash-119-70,34570,464466,0617,84911,544-340,803167,98655,9916,80417,71210,165126,547

P&L

March 2022

turnover

42.8k

-30%

operating profit

-35.2k

0%

gross margin

20.4%

+7.57%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2022

net assets

-15.2k

-1.76%

total assets

0

-1%

cash

0

-1%

net assets

Total assets minus all liabilities

mymedpharma limited company details

company number

05504955

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

July 2005

age

19

accounts

Unaudited Abridged

ultimate parent company

previous names

N/A

incorporated

UK

address

mymed house, 95 -97 johnston street, blackburn, lancashire, BB2 1HY

last accounts submitted

March 2022

mymedpharma limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to mymedpharma limited.

charges

mymedpharma limited Companies House Filings - See Documents

datedescriptionview/download